Parkinson's disease associated with 22q11.2 deletion: Clinical characteristics and response to treatment
B. Dufournet1,2, K. Nguyen3,2, P. Charles4,5, D. Grabli6,5, A. Jacquette4,5, M. Borg7, T. Danaila8,9, E. Mutez10,11, S. Drapier12,13, O. Colin14,15, A. Eusebio1,2, N. Philip3,2, J.P. Azulay1,16
1Department of Clinical Neurosciences (Movement Disorders), Timone University Hospital (AP-HM), 264 rue Saint Pierre, 13385 Marseille Cedex 5, France
2Aix-Marseille University, Marseille, France
3Department of Genetics (Neurogenetics), Timone University Hospital (AP-HM), Marseille, France
4Department of Genetics (Neurogenetics), Pitié-Salpêtrière University Hospital (AP-HP), Paris, France
5Sorbonne University, UPMC Paris 06 (UMR S 1127, CNRS UMR 7225, ICM), Paris, France
6Department of Neurology (Movement Disorders), Pitié-Salpêtrière University Hospital (AP-HP), Paris, France
7Department of Clinical Neurosciences (Movement Disorders), Nice University Hospital, Nice, France
8Department of Neurology (Movement Disorders), Pierre Wertheimer University Hospital (HCL), Lyon, France
9Lyon-1 University, Marc Jeannerod Center for Cognitives Neurosciences (CNRS UMR 5229), Lyon, France
10Department of Neurosciences (Movement Disorders), Lille University Hospital, Lille, France
11Lille University (INSERM U1171), Lille, France
12Department of Neurology (Movement Disorders), Rennes University Hospital, Rennes, France
13Rennes-1 University (URU 4712 “Basal Ganglia & Behavior”), Rennes, France
14Department of Neurology (Movement Disorders), Poitiers University Hospital, Poitiers, France
15Clinical Investigation Center (INSERM CIC 0802 & INSERM U1084, Clinical and Experimental Neurosciences), Poitiers University Hospital, Poitiers, France
16Aix Marseille University, Marseille France
Thông tin
Thông tin xuất bản
Revue Neurologique
Tập 173
406-410
Thông tin tác giả